Lexus India Limited
About Lexus India Limited
Data last updated:
Lexus India Limited is a public limited company based in New Delhi, Delhi, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 1992.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL1992PLC048996. Its GSTIN is 05AAACL6145N1ZC (Uttarakhand).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.23 Cr. It is led by directors including Pramod Kumar Saraf (Managing Director) and Sandeep Kumar Kandoi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H – 25 First Floor Kailash Colony, New Delhi, Delhi, India – 110048.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.32 Cr, a growth of 99% compared to the previous year. For the same year it recorded a net loss of ₹77.96 Lakh (net margin -14.7%) and EBITDA of -₹60.81 Lakh (EBITDA margin -11.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 44% over five years.
The company is associated with 1 brand: Lexus India. As per MCA filings, the company has open charges of ₹6.6 Cr on record. Court records list 58 cases involving the company, including 2 filed by the company and 56 filed against it; 4 cases are pending.
Company details
Contact details
Lexus India Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH – 25 First Floor Kailash Colony, New Delhi, Delhi, India – 110048
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lexus India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lexus India operates one associated brand: Lexus India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Luxury vehicles are manufactured and distributed by Lexus globally. | lexusindia.co.in |
Business activity
The main business activity of Lexus India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lexus India Limited, buy the company report.
Financials of Lexus India Limited
FY 2024 filings availableLexus India Limited reported revenue of ₹5.32 Cr (up 99% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 99% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5.32 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹60.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹77.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.4% | ||||
| Net Profit Margin | -14.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lexus India Limited, buy the company report.
Board of directors of Lexus India Limited
Lexus India has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Kumar Saraf Also directs: Eaco Labs Limited, Magadh Enterprises Private Limited | Managing Director | 30 Nov 2000 | 25 Years 11 Months | As last reported |
| Sandeep Kumar Kandoi Also directs: Ashirwad Biofuels LLP, Ashirwad Biofuels Private Limited | Director | 19 Apr 2007 | 19 Years 6 Months | As last reported |
| Shubham Saraf | Director | 30 Apr 2018 | 8 Years 6 Months | As last reported |
| Satish Agarwal Also directs: Life Line Biotech Limited | Director | 01 Jun 1992 | 34 Years 5 Months | As last reported |
| Kusum Saraf Also directs: Eaco Labs Limited, Magadh Enterprises Private Limited | Director | 15 May 2002 | 24 Years 5 Months | As last reported |
Peer comparison
Lexus India Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A R K Health Care Pvt Ltd | ₹5.32 Cr (FY 2024) | -34.0% | Manimajra, Chandigarh, India | |||
| Harihar Pharmaceuticals Private Limited | ₹5.32 Cr (FY 2025) | 7.0% | Bolangir, Odisha, India | |||
| Lexus India Limitedthis company | ₹5.32 Cr (FY 2024) | -₹77.96 Lakh | -14.7% | 99.0% | New Delhi, Delhi, India | |
| Meticulous Pharmaceticals Private Limited | ₹5.31 Cr (FY 2025) | 36.0% | Uttar Pradesh, India | |||
| Swastik Formulations Private Limited | ₹5.3 Cr (FY 2025) | 13.0% | Uttar Pradesh, India | |||
| Nupur Pharma Private Limited | ₹5.3 Cr (FY 2025) | -6.0% | Delhi, India | |||
| Edence Life Sciences Private Limited | ₹5.29 Cr (FY 2024) | 17.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Lexus India Limited, buy the company report.
Auditor
Lexus India Limited is audited by SANJAY REMMY & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY REMMY & CO | FY 2024 | 012349N |
Shareholding
The shareholding of Lexus India Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lexus India Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2007 | 10076748 | Bank of India | ₹2 Cr | Open | |
| 11 Nov 2006 | 90333931 | Small Industries Development Bank of India | ₹4.6 Cr | Open |
To see the full charge records of Lexus India Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Lexus India Limited has 58 court cases on record: 2 filed by Lexus India, 56 filed against it. 4 cases are pending and 54 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 52 | 51 | 4 |
| High courts | 4 | 3 | 0 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 58)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Execution petition | Filed against the company by Shamshree International P Ltd | Pending |
| District court, Muzaffarnagar, Uttar Pradesh | Court case (Original Suit) | Filed against the company by Trends Remedies Pvt. Ltd. | Disposed |
| NCLT, New Delhi Bench Court-III | Insolvency matter | Filed against the company by Himalayan Packaging Industries Pvt. Ltd. | Disposed |
| District court, Chandigarh | Court case (MCA DJ) | Filed against the company by Shamshree International Pvt Ltd | Disposed |
| District court, Chandigarh | Civil miscellaneous application | Filed against the company by Shamshree International Pvt Ltd | Disposed |
To see the full case history of Lexus India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lexus India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lexus India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACL6145N1ZC | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lexus India Limited, buy the company report.
Recent activity
Lexus India Limited has 10 board changes on record since 1992: 5 appointments and 5 cessations. The latest: Shubham Saraf ceased to be Additional Director on 29 Sep 2018.
4 earlier events are in the company report.
News
Frequently asked questions
Lexus India is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Lexus India is a company under insolvency, formerly operating as a public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 1992 and is registered under CIN U51909DL1992PLC048996. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Lexus India has 5 current directors:
- Pramod Kumar Saraf - Managing Director
- Sandeep Kumar Kandoi - Director
- Shubham Saraf - Director
- Satish Agarwal - Director
- Kusum Saraf - Director
The latest financial statements of Lexus India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Lexus India is U51909DL1992PLC048996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lexus India has open charges of ₹6.6 Cr and no satisfied charges on record as per latest MCA filings.
Lexus India has 58 court cases on record: 2 filed by the company and 56 filed against it. 4 are pending. Most are in the district courts.
Lexus India was incorporated on 01 June 1992. It is registered with the Registrar of Companies, Delhi.
The peers of Lexus India by revenue are A R K Health Care Pvt Ltd, Harihar Pharmaceuticals Private Limited, Meticulous Pharmaceticals Private Limited, Swastik Formulations Private Limited, Nupur Pharma Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shubham Saraf ceased to be Additional Director on 29 Sep 2018. Satish Agarwal ceased to be Director on 30 Apr 2018. Shubham Saraf was appointed as Director on 30 Apr 2018. Lexus India has 10 board changes on record in total.
The registered office of Lexus India is at H – 25 First Floor Kailash Colony, New Delhi, Delhi, India – 110048.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
